Search | IOVS | ARVO Journals

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract April 2014

Development of an in vitro model of proliferative vitreoretinopathy using iPS-RPE

Whitney Greene; Alberto Muniz; Anthony James Johnson; Heuy-Ching Hetty Wang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1097. doi:

ARVO Annual Meeting Abstract April 2014

Retinoid Uptake, Processing and Secretion in Human iPS-RPE Support the Visual Cycle

Alberto Muniz; Whitney Greene; Mark Plamper; Jae Hyek Choi; Anthony James Johnson; Andrew T C Tsin; Heuy-Ching Hetty Wang

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3467. doi:

ARVO Annual Meeting Abstract June 2013

Human iPS-RPE Synthesize and Release 11- cis Retinaldehyde from Exogenous All- trans Retinol

Alberto Muniz; Mark Plamper; Jae Hyek Choi; Whitney Greene; Anthony Johnson; Andrew Tsin; Heuy-Ching Wang

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3763. doi:

ARVO Annual Meeting Abstract June 2013

Differential miRNA expression profile of early passage iPS-RPE compared to later passage iPS-RPE

Heuy-Ching Wang; Alberto Muniz; Mark Plamper; Jae Hyek Choi; Whitney Greene; Retina Cell Biology

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2228. doi:

ARVO Annual Meeting Abstract March 2012

Visual Cycle Machinery in Human Induced Pluripotent Stem Cell-Derived RPE

Alberto Muniz; Mark L. Plamper; Brandi S. Betts; Anthony J. Johnson; Heuy-Ching H. Wang

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5903. doi:

ARVO Annual Meeting Abstract April 2011

Size of Embryoid Body Influences the Differentiation Efficiency of iPS into RPE

Alberto Muniz; Douglas Grow; Dallas Golden; Heuy-Ching Wang

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3189. doi:

Advertisement